Used in pharmaceutical research as a key intermediate for developing kinase inhibitors, particularly in oncology. Shows potential in targeting receptor tyrosine kinases involved in tumor growth and angiogenesis. Also explored for its antiviral properties, especially against RNA viruses, due to its ability to interfere with viral replication pathways. Its structure supports binding to ATP sites in enzymes, making it valuable in designing selective inhibitors. Currently under investigation in preclinical studies for anti-inflammatory and neuroprotective applications.